Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
暂无分享,去创建一个
S. Susen | L. Agier | P. Albaladéjo | E. de Maistre | T. Lecompte | J. Levy | A. Godier | F. Mullier | Z. Durand | C. Tacquard | R. Marlu | A. Godon
[1] T. Lecompte,et al. Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study , 2021, TH Open.
[2] S. Susen,et al. Anticoagulation in COVID-19: not strong for too long? , 2021, Anaesthesia Critical Care & Pain Medicine.
[3] P. Morange,et al. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia , 2021, Chest.
[4] S. Laporte,et al. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study , 2020, Hämostaseologie.
[5] M. Ohana,et al. D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients , 2020, Journal of clinical medicine.
[6] Dong Chen,et al. Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection , 2020, Blood.
[7] P. Morange,et al. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring , 2020, Critical Care.
[8] M. Refaai,et al. The Clinical Significance of Fibrin Monomers , 2018, Thrombosis and Haemostasis.
[9] Masato Sato,et al. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty , 2015, Journal of Orthopaedic Surgery and Research.
[10] M. Spannagl,et al. The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis. , 1996, Thrombosis research.